Robert W. Mutter

2.8k total citations
84 papers, 1.6k citations indexed

About

Robert W. Mutter is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Robert W. Mutter has authored 84 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cancer Research, 24 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Robert W. Mutter's work include Breast Cancer Treatment Studies (33 papers), Advanced Radiotherapy Techniques (19 papers) and Breast Implant and Reconstruction (17 papers). Robert W. Mutter is often cited by papers focused on Breast Cancer Treatment Studies (33 papers), Advanced Radiotherapy Techniques (19 papers) and Breast Implant and Reconstruction (17 papers). Robert W. Mutter collaborates with scholars based in United States, France and Netherlands. Robert W. Mutter's co-authors include Judy C. Boughey, Kimberly S. Corbin, Carolyn Cao, Jeffrey M. Albert, Kwang Woon Kim, Sean S. Park, Mohamed M. Kahila, Lindsay C. Brown, Jiahong Lu and Dennis E. Hallahan and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Circulation.

In The Last Decade

Robert W. Mutter

70 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert W. Mutter United States 22 523 483 418 374 288 84 1.6k
Gillian C. Barnett United Kingdom 22 535 1.0× 684 1.4× 728 1.7× 465 1.2× 545 1.9× 41 2.1k
Skye Hongiun Cheng Taiwan 23 562 1.1× 382 0.8× 420 1.0× 269 0.7× 187 0.6× 32 1.7k
Sang‐Hue Yen Taiwan 23 512 1.0× 250 0.5× 315 0.8× 390 1.0× 126 0.4× 52 1.8k
Anne E. Kiltie United Kingdom 32 571 1.1× 450 0.9× 495 1.2× 1.3k 3.4× 184 0.6× 78 2.5k
Thierry Muanza Canada 21 382 0.7× 312 0.6× 694 1.7× 380 1.0× 108 0.4× 68 1.6k
Giovanna Masci Italy 21 789 1.5× 526 1.1× 376 0.9× 471 1.3× 42 0.1× 73 1.6k
Ji Hyun Chang South Korea 19 361 0.7× 299 0.6× 298 0.7× 201 0.5× 92 0.3× 85 1.1k
Gregory N. Gan United States 20 807 1.5× 239 0.5× 954 2.3× 572 1.5× 239 0.8× 60 1.8k
Eric Hau Australia 16 324 0.6× 478 1.0× 385 0.9× 428 1.1× 131 0.5× 54 1.3k
Arta M. Monjazeb United States 34 1.6k 3.1× 268 0.6× 966 2.3× 550 1.5× 119 0.4× 123 3.2k

Countries citing papers authored by Robert W. Mutter

Since Specialization
Citations

This map shows the geographic impact of Robert W. Mutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Mutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Mutter more than expected).

Fields of papers citing papers by Robert W. Mutter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Mutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Mutter. The network helps show where Robert W. Mutter may publish in the future.

Co-authorship network of co-authors of Robert W. Mutter

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Mutter. A scholar is included among the top collaborators of Robert W. Mutter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Mutter. Robert W. Mutter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kloeber, Jake A., Michael G. Haddock, Yasamin Sharifzadeh, et al.. (2026). Clinical Evidence on Particle Radiation, DNA Damage Response Inhibitors, and Immunotherapy for Mismatch Repair-Proficient Rectal Cancer. Cancers. 18(4). 652–652.
2.
Kloeber, Jake A., Bin Chen, Guangchao Sun, et al.. (2025). KCTD10 is a sensor for co-directional transcription–replication conflicts. Nature. 648(8092). 210–219.
3.
Ma, Jiasen, Nicholas B. Remmes, Jake A. Kloeber, et al.. (2025). Linear energy transfer optimized proton therapy for rectal cancer. Radiotherapy and Oncology. 207. 110850–110850. 1 indexed citations
4.
Han, Yiqun, Qin Zhou, Bin Chen, et al.. (2025). Poly ADP Ribose Polymerase Inhibitors Potentiate Proton Therapy End-of-Range Effects by Accelerating Replication Forks and Promoting Transcription Conflict. International Journal of Radiation Oncology*Biology*Physics. 124(2). 451–464.
5.
6.
Choi, J. Isabelle, Alicia Lozano, Alexandra L. Hanlon, et al.. (2024). PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer. Clinical and Translational Radiation Oncology. 48. 100847–100847. 2 indexed citations
7.
Mutter, Robert W., Cynthia Chauhan, Matthew P. Goetz, & Jean L. Wright. (2024). Revisiting Combined Modality Therapy in Older Patients With Luminal Breast Cancer Through the Patient Lens. Journal of Clinical Oncology. 42(18). 2121–2125. 1 indexed citations
8.
Hanlon, Alexandra L., Carlos Vargas, John H. Maduro, et al.. (2024). Ptcog International Survey of Practice Patterns and Trends in Utilization of Proton Therapy for Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(2). e742–e743.
9.
Corbin, Kimberly S., Diego A.S. Toesca, C.S. Thorpe, et al.. (2023). Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery. International Journal of Radiation Oncology*Biology*Physics. 118(4). 1049–1059. 8 indexed citations
10.
Corbin, Kimberly S., C.S. Thorpe, Diego A.S. Toesca, et al.. (2023). Physician and Patient-Reported Outcomes of a Phase III Trial of Ultra-Hypofractionated vs. Moderate Hypofractionated Radiotherapy to the Whole Breast after Breast-Conserving Surgery. International Journal of Radiation Oncology*Biology*Physics. 117(2). S6–S6. 1 indexed citations
11.
Gao, Robert W., William S. Harmsen, Trey C. Mullikin, et al.. (2023). Proton vs. Photons for Breast Cancer Patients with Immediate, Implant-Based Reconstruction Receiving Postmastectomy Radiotherapy: A Multicenter Pooled Analysis. International Journal of Radiation Oncology*Biology*Physics. 117(2). S175–S175.
12.
Yadav, Siddhartha, Lindsey R. Sangaralingham, Stephanie Payne, et al.. (2022). Surveillance mammography after treatment for male breast cancer. Breast Cancer Research and Treatment. 194(3). 693–698. 1 indexed citations
13.
Zhou, Qin, Xinyi Tu, Qian Zhu, et al.. (2021). Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining. Cancer Research. 81(12). 3333–3346. 30 indexed citations
14.
Zhou, Qin, Jinzhou Huang, Chao Zhang, et al.. (2020). The bromodomain containing protein BRD-9 orchestrates RAD51–RAD54 complex formation and regulates homologous recombination-mediated repair. Nature Communications. 11(1). 2639–2639. 47 indexed citations
15.
Yadav, Siddhartha, Irbaz Bin Riaz, Hao Xie, et al.. (2019). Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century. Cancer. 126(1). 26–36. 90 indexed citations
16.
Jethwa, Krishan R., Jason K. Viehman, William S. Harmsen, et al.. (2019). Post-mastectomy intensity modulated proton therapy after immediate breast reconstruction: Initial report of reconstruction outcomes and predictors of complications. Radiotherapy and Oncology. 140. 76–83. 32 indexed citations
17.
Tu, Xinyi, Mohamed M. Kahila, Qin Zhou, et al.. (2018). ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 17(11). 2462–2472. 71 indexed citations
18.
Mutter, Robert W., Sean S. Park, Tina J. Hieken, et al.. (2018). Carbon Fiducial Image Guidance Increases the Accuracy of Lumpectomy Cavity Localization in Radiation Therapy for Breast Cancer. Practical Radiation Oncology. 9(1). e14–e21. 1 indexed citations
19.
Mutter, Robert W., Mohamed M. Kahila, Xiaolin Yu, et al.. (2017). The Selective ATR Inhibitor VX-970 Enhances the Therapeutic Effects of Radiation Therapy in Triple Negative Breast Cancer Patient-Derived Xenografts and is a Novel Strategy to Overcome Therapeutic Resistance. International Journal of Radiation Oncology*Biology*Physics. 99(2). E611–E611. 2 indexed citations
20.
Kim, Kwang Woon, Robert W. Mutter, Carolyn Cao, et al.. (2006). Autophagy for Cancer Therapy through Inhibition of Pro-apoptotic Proteins and Mammalian Target of Rapamycin Signaling. Journal of Biological Chemistry. 281(48). 36883–36890. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026